NCT04484870View on ClinicalTrials.gov

Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 30, 2018

Study Completion Date

July 20, 2019

Conditions
CholedocholithiasisRecurrence
Interventions
DRUG

oral Danshu capsule

Danshu group oral Danshu capsule, 2 tablets per time, 3 times a day (0.45g/ tablets, Sichuan Jishengtang Pharmaceutical Co., Ltd.)

Trial Locations (1)

310000

Hangzhou first people's Hospital, Hangzhou

All Listed Sponsors
lead

First People's Hospital of Hangzhou

OTHER

NCT04484870 - Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis | Biotech Hunter | Biotech Hunter